Cargando…
Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting
BACKGROUND: Flecainide and propafenone are Class Ic antiarrhythmic drugs that block the cardiac fast inwards Na(+) current and are used for rhythm control in patients with atrial fibrillation (AF). However, data on long-term clinical efficacy and safety of these drugs in a real-world setting are sca...
Autores principales: | Kovacs, Boldizsar, Yakupoglu, Haci Yakup, Eriksson, Urs, Krasniqi, Nazmi, Duru, Firat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987554/ https://www.ncbi.nlm.nih.gov/pubmed/36510792 http://dx.doi.org/10.5603/CJ.a2022.0116 |
Ejemplares similares
-
Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?
por: Kovacs, Boldizsar, et al.
Publicado: (2018) -
Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone
por: Holmes, Andrew P., et al.
Publicado: (2021) -
Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol
por: Kojić, Dejan, et al.
Publicado: (2023) -
Beta(1)-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation
por: Nia, Amir M., et al.
Publicado: (2010) -
Propafenone Poisoning of a Female Adolescent After a Suicide Attempt
por: Keramari, Stergiani, et al.
Publicado: (2021)